Fluorescent substances in uremic and normal serum

Area of Science:

• Biochemistry
• Nephrology
• Analytical Chemistry

Background:

• Chronic renal failure (CRF) alters serum composition.
• Uremic toxins and altered metabolites are characteristic of CRF.
• Novel biomarkers for CRF are needed for improved diagnostics.

Purpose of the Study:

• To investigate novel fluorescence properties of serum ultrafiltrates and fractions in patients with chronic renal failure.
• To identify and characterize previously undescribed fluorescence spectra in uremic serum.
• To compare fluorescence profiles between normal subjects and CRF patients undergoing hemodialysis.

Main Methods:

• Serum ultrafiltrates and fractions from Sephadex G15 chromatography were analyzed.
• Fluorescence spectroscopy was performed at various excitation (Ex) and emission (Em) wavelengths.
• Serum filtration across membranes with varying molecular weight cutoffs (10,000 to 500 Da) was conducted.

Main Results:

• Previously undescribed fluorescence was detected at Ex 380 nm/Em 440 nm and Ex 400 nm/Em 460 nm.
• These fluorescence intensities were significantly higher in CRF patients compared to normal subjects (p < 0.005).
• The fluorescence persisted across different molecular weight cutoffs and was most intense in higher molecular weight serum fractions.

Conclusions:

• The study identified novel, elevated fluorescence signatures in the serum of patients with chronic renal failure.
• These findings suggest potential for new fluorescence-based biomarkers for diagnosing and monitoring kidney disease.
• The characterized fluorescence is associated with higher molecular weight components in uremic serum.